Alembic Pharmaceuticals Ltd.

Financial

	Alembic Pharma	Pfizer	Natco Pharma
Operational Metrics
API Sector
US DMF Filings	135.0 .	n/a	58.0 .
Pharmaceutical Sector
Number of ANDA's Filed in USA	263.0 .	n/a	51.0 .
Number of ANDA's Approved By USFDA	219.0 .	n/a	41.0 .
Number of ANDA's Filed in Latam	14.0	n/a	n/a
Number of ANDA's Approved by Latam	4.0	n/a	n/a
Number of ANDA's Filed in South Africa	21.0	n/a	n/a
Number of ANDA's Approved by South Africa	7.0	n/a	n/a
Number of ANDA's Filed in Australia	17.0	n/a	n/a
Number of ANDA's Approved by Australia	14.0	n/a	n/a
Number of ANDA's Filed in Canada	21.0	n/a	n/a
Number of ANDA's Approved by Canada	20.0	n/a	n/a
Number of ANDA's Filed in Europe	21.0	n/a	n/a
Number of ANDA's Approved in Europe	19.0	n/a	n/a
R&D as a % of Total Sales	7.0 %	n/a	7.6 %
Financials
5 yr Average ROE	15.79 %	18.39 %	13.06 %
5yr average Equity Multiplier	1.48	1.28	1.18
5yr Average Asset Turnover Ratio	0.83	0.6	0.46
5yr Avg Net Profit Margin	13.0 %	24.04 %	23.09 %
Price to Book	3.54	5.21	2.26
P/E	28.65	31.75	8.68
5yr Avg Cash Conversion Cycle	1.45 Days	-2.02 Days	10.54 Days
Inventory Days	94.67 Days	49.44 Days	99.95 Days
Days Receivable	60.69 Days	26.74 Days	86.16 Days
Days Payable	176.63 Days	81.1 Days	154.15 Days
5yr Average Interest Coverage Ratio	36.16	170.95	46.61
5yr Avg ROCE	17.34 %	23.56 %	16.05 %
5yr Avg Operating Profit Margin	19.56 %	30.56 %	30.17 %
5 yr average Debt to Equity	0.2	0.0	0.06
5yr CAGR Net Profit	-5.77 %	65.36 %	24.68 %
5yr Average Return on Assets	10.48 %	14.39 %	11.07 %
Shareholdings
Promoter Holding	69.67 %	63.92 %	49.56 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.06 %	0.0	0.75 %
Change in Mutual Fund Holding (3 Yrs)	4.02 %	3.65 %	-5.54 %

Business

	Alembic Pharma	Pfizer	Natco Pharma
Product Wise Break-Up	Product Wise Break-Up Formulations 84.7 Active Pharmaceutical Ingredient (API) 15.3 Pharmaceutical 0 Crop Health 0 API(Domestic & Exports) 0 Formulation 0	Product Wise Break-Up Crop Health 0 Pharmaceutical 100.0 API(Domestic & Exports) 0 Formulations 0 Formulation 0 Active Pharmaceutical Ingredient (API) 0	Product Wise Break-Up Crop Protection 2.0 Pharmaceutical 0 Active Pharmaceutical Ingredient (API) 10.0 Formulations 0 Formulations 59.0 Active Pharmaceutical Ingredient (API) 0 Others 29.0
Product Wise Break-Up	Product Wise Break-Up Formulations 84.7 Active Pharmaceutical Ingredient (API) 15.3 Pharmaceutical 0 Crop Health 0 API(Domestic & Exports) 0 Formulation 0	Product Wise Break-Up Crop Health 0 Pharmaceutical 100.0 API(Domestic & Exports) 0 Formulations 0 Formulation 0 Active Pharmaceutical Ingredient (API) 0	Product Wise Break-Up Crop Protection 2.0 Pharmaceutical 0 Active Pharmaceutical Ingredient (API) 10.0 Formulations 0 Formulations 59.0 Active Pharmaceutical Ingredient (API) 0 Others 29.0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 60.12 India 39.88 USA 0	Location Wise Break-Up India 96.14 Rest of the World 3.86 USA 0	Location Wise Break-Up India 14.27 Rest of the World 15.24 USA 70.49
Therapeutic Area Break-Up	Therapeutic Area Break-Up Others 100	-	-

Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd.

SIGN UP FOR FREE